AngioDynamics (NASDAQ:ANGO) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS

by · The Cerbat Gem

AngioDynamics (NASDAQ:ANGO – Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.04, Briefing.com reports. The firm had revenue of $67.50 million for the quarter, compared to the consensus estimate of $67.93 million. AngioDynamics had a negative return on equity of 4.91% and a negative net margin of 61.55%. The firm’s revenue was down 14.2% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.12) earnings per share. AngioDynamics updated its FY25 guidance to ($0.42)-($0.38) EPS and its FY 2025 guidance to -0.420–0.380 EPS.

AngioDynamics Trading Down 4.2 %

ANGO stock traded down $0.27 during trading on Friday, hitting $6.10. The company had a trading volume of 1,310,782 shares, compared to its average volume of 522,570. The company has a fifty day moving average price of $7.48 and a two-hundred day moving average price of $6.62. AngioDynamics has a fifty-two week low of $5.26 and a fifty-two week high of $8.25. The company has a market cap of $244.34 million, a P/E ratio of -1.26 and a beta of 0.65.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on ANGO shares. HC Wainwright reaffirmed a “buy” rating and set a $14.00 target price on shares of AngioDynamics in a research report on Friday. Canaccord Genuity Group decreased their target price on AngioDynamics from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, AngioDynamics has a consensus rating of “Moderate Buy” and an average target price of $12.00.

Check Out Our Latest Research Report on ANGO

About AngioDynamics

(Get Free Report)

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.

Featured Stories